Inhibrx

Inhibrx is a clinical-stage biotechnology company based in La Jolla, California, United States. The company is focused on developing innovative therapeutic candidates, leveraging its protein-engineering expertise and proprietary single-domain antibody platform. Inhibrx has built a unique and varied pipeline of novel therapeutic candidates, driven by a team of experienced scientists and a commitment to scientific excellence.